These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 25676808)

  • 21. [Safety and short-term efficacy of renal sympathetic denervation in the treatment of resistant hypertension].
    Jiang XJ; Liang T; Dong H; Peng M; Ma WJ; Guan T; Zhang HM; Bian J; Xu B; Gao RL
    Zhonghua Yi Xue Za Zhi; 2012 Dec; 92(46):3265-8. PubMed ID: 23328511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and Safety of Radiofrequency-Based Renal Denervation on Resistant Hypertensive Patients: A Systematic Review and Meta-analysis.
    Sobreira LER; Bezerra FB; Sano VKT; de Oliveira Macena Lôbo A; Cardoso JHCO; Kelly FA; de Moraes FCA; Consolim-Colombo FM
    High Blood Press Cardiovasc Prev; 2024 Jul; 31(4):329-340. PubMed ID: 38890242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Catheter-based renal denervation for treatment of resistant hypertension.
    Vase H; Mathiassen ON; Kaltoft A; Pedersen EB; Christensen KL; Buus NH; Lederballe O; Lassen JF; Bøtker HE; Thuesen L
    Dan Med J; 2012 Jun; 59(6):A4439. PubMed ID: 22677237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treating resistant hypertension with new devices.
    Wienemann H; Meincke F; Kaiser L; Heeger CH; Bergmann MW
    Minerva Cardioangiol; 2014 Jun; 62(3):235-41. PubMed ID: 24831759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal denervation in the antihypertensive arsenal - knowns and known unknowns.
    Messerli FH; Bavishi C; Brguljan J; Burnier M; Dobner S; Elijovich F; Ferdinand KC; Kjeldsen S; Laffer CL; S Ram CV; Rexhaj E; Ruilope LM; Shalaeva EV; Siontis GCM; Staessen JA; Textor SC; Vongpatanasin W; Vogt L; Volpe M; Wang J; Williams B
    J Hypertens; 2022 Oct; 40(10):1859-1875. PubMed ID: 36052518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substantial reduction in single sympathetic nerve firing after renal denervation in patients with resistant hypertension.
    Hering D; Lambert EA; Marusic P; Walton AS; Krum H; Lambert GW; Esler MD; Schlaich MP
    Hypertension; 2013 Feb; 61(2):457-64. PubMed ID: 23172929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of renal denervation added to standard pharmacologic treatment versus standard pharmacologic treatment alone in patients with resistant hypertension: rationale and design of the SYMPATHY trial.
    Vink EE; de Beus E; de Jager RL; Voskuil M; Spiering W; Vonken EJ; de Wit GA; Roes KC; Bots ML; Blankestijn PJ
    Am Heart J; 2014 Mar; 167(3):308-314.e3. PubMed ID: 24576513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3.
    Bakris GL; Townsend RR; Liu M; Cohen SA; D'Agostino R; Flack JM; Kandzari DE; Katzen BT; Leon MB; Mauri L; Negoita M; O'Neill WW; Oparil S; Rocha-Singh K; Bhatt DL;
    J Am Coll Cardiol; 2014 Sep; 64(11):1071-8. PubMed ID: 24858423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal denervation in treatment-resistant hypertension - Oslo RDN, Symplicity HTN-3 and INSPiRED randomized trials.
    Kjeldsen SE; Narkiewicz K; Oparil S; Hedner T
    Blood Press; 2014 Jun; 23(3):135-7. PubMed ID: 24842262
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of renal sympathetic denervation on heart rate and atrioventricular conduction in patients with resistant hypertension.
    Ukena C; Mahfoud F; Spies A; Kindermann I; Linz D; Cremers B; Laufs U; Neuberger HR; Böhm M
    Int J Cardiol; 2013 Sep; 167(6):2846-51. PubMed ID: 22917547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Renal denervation a new treatment option in resistant arterial hypertension].
    Himmel F; Bode F; Schunkert H; Weil J
    Praxis (Bern 1994); 2011 Nov; 100(22):1353-60. PubMed ID: 22048911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. First-in-human use of the OneShot™ renal denervation system from Covidien.
    Ormiston JA; Watson T; van Pelt N; Stewart R; Haworth P; Stewart JT; Webster MW
    EuroIntervention; 2013 Jan; 8(9):1090-4. PubMed ID: 23339814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal sympathetic nerve denervation for the treatment of resistant hypertension.
    Palmer SC; Judkins C; Williams PD; Whitbourn RJ
    Med J Aust; 2013 Aug; 199(3):160-2. PubMed ID: 23909527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension.
    Mahfoud F; Ukena C; Schmieder RE; Cremers B; Rump LC; Vonend O; Weil J; Schmidt M; Hoppe UC; Zeller T; Bauer A; Ott C; Blessing E; Sobotka PA; Krum H; Schlaich M; Esler M; Böhm M
    Circulation; 2013 Jul; 128(2):132-40. PubMed ID: 23780578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Catheter-based renal sympathetic denervation: limitations to and gaps in the evidence.
    Hiremath S; Froeschl M; Ruzicka M
    Curr Opin Cardiol; 2014 Jul; 29(4):336-43. PubMed ID: 24859619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of renal denervation therapy for resistant hypertension: a systematic review and meta-analysis.
    Davis MI; Filion KB; Zhang D; Eisenberg MJ; Afilalo J; Schiffrin EL; Joyal D
    J Am Coll Cardiol; 2013 Jul; 62(3):231-241. PubMed ID: 23644092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Interventional renal sympathetic denervation - a new approach for patients with resistant hypertension].
    Mahfoud F; Böhm M
    Dtsch Med Wochenschr; 2010 Dec; 135(48):2422-5. PubMed ID: 21108158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Results of the ALSTER BP real-world registry on renal denervation employing the Symplicity system.
    Kaiser L; Beister T; Wiese A; von Wedel J; Meincke F; Kreidel F; Busjahn A; Kuck KH; Bergmann MW
    EuroIntervention; 2014 May; 10(1):157-65. PubMed ID: 24472799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal denervation in the management of resistant hypertension: current evidence and perspectives.
    Jin Y; Persu A; Staessen JA
    Curr Opin Nephrol Hypertens; 2013 Sep; 22(5):511-8. PubMed ID: 23892701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential lifetime cost-effectiveness of catheter-based renal sympathetic denervation in patients with resistant hypertension.
    Dorenkamp M; Bonaventura K; Leber AW; Boldt J; Sohns C; Boldt LH; Haverkamp W; Frei U; Roser M
    Eur Heart J; 2013 Feb; 34(6):451-61. PubMed ID: 23091202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.